0001140361-23-012596.txt : 20230320
0001140361-23-012596.hdr.sgml : 20230320
20230320173552
ACCESSION NUMBER: 0001140361-23-012596
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230317
FILED AS OF DATE: 20230320
DATE AS OF CHANGE: 20230320
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sullivan Amy
CENTRAL INDEX KEY: 0001887865
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41008
FILM NUMBER: 23747285
MAIL ADDRESS:
STREET 1: 38 OUTLOOK ROAD
CITY: SWAMPSCOTT
STATE: MA
ZIP: 01907
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IO Biotech, Inc.
CENTRAL INDEX KEY: 0001865494
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 870909276
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: OLE MAALOES VEH 3
CITY: COPENHAGEN
STATE: G7
ZIP: 2200
BUSINESS PHONE: 4570702980
MAIL ADDRESS:
STREET 1: OLE MAALOES VEH 3
CITY: COPENHAGEN
STATE: G7
ZIP: 2200
4
1
form4.xml
X0407
4
2023-03-17
0001865494
IO Biotech, Inc.
IOBT
0001887865
Sullivan Amy
C/O IO BIOTECH, INC.
OLE MAALOES VEH 3
COPENHAGEN
G7
2200
DENMARK
true
Chief Financial Officer
false
Common Stock
2023-03-17
4
P
0
25000
2.3207
A
25000
D
The transaction was executed in multiple trades in prices ranging from $2.18 to $2.46, inclusive. The price reported in Column 4 above reflects the weighted average purchase price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each respective price within the range set forth in this footnote.
/s/ Brian Burkavage, Attorney-in-Fact for Amy Sullivan
2023-03-20